newsfilter
← Latest News
Business Wire·

4D pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson's Disease

- IND clearance marks the expansion of 4D pharma's clinical-stage pipeline of single strain Live Biotherapeutics into neurology - First US FDA IND clearance for a Live Biotherapeutic for Parkinson's disease 4D pharma plc ((AIM: DDDD, NASDAQ:LBPS),